Clinical Trials Browser

Unknown × Triple Negative Breast Neoplasms × Vinorelbine × Clear all

NCT04745975 2022-04-20

Guided Treatment Based on Mini-PDX in Metastatic Triple Negative Breast Cancer

Phase 2 Unknown

Triple Negative Breast Neoplasms

NCT03932526 2019-04-30

Combined Use of Apatinib Mesylate and Vinorelbine Versus Single Use of Vinorelbine in Triple-negative Breast Cancer

Phase 2 Unknown

Triple Negative Breast Neoplasms

NCT01528826 2012-02-08

NVBOX

Phase 2 Unknown

Breast Neoplasms, Triple Negative Breast Neoplasms